Sbir topic area 058
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93018C00018
- Awardee
-
Melax Technologies Inc. UEI ME3MA61LJD79
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $599,998
Award facts
- Opportunity
-
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (sbir) contract proposals Pre-Solicitation · PHS20181 · Posted Jun 29, 2017
- Contract value 100% obligated
- $599,998.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Houston, TX 77021, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Vendor Address Change | $0 | |
| Original award | $599,998 |
About this award
This is a $599,998.00 firm fixed price contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Melax Technologies Inc., a for-profit small business. The contract was awarded under the Small Business Innovation Research (SBIR) program, which does not have a set-aside designation, to conduct research and development of advanced data analytics technologies focused on healthcare applications. The work is being performed in Houston, TX and is scheduled for completion on July 31, 2020.
The contract was awarded under the SBIR PHS 2018-1 solicitation, which covered a range of topic areas for the NIH and Centers for Disease Control and Prevention (CDC), including methods for improving HIV protein expression, high-throughput assays for quantifying latent HIV reservoirs, and development of bioinformatics tools to make data more findable, accessible, interoperable, and reusable. As a prime contractor, Melax Technologies has also been awarded over $1 million in prior federal contracts from NIH and the National Cancer Institute for research supporting their missions.
Quick answers
Who was awarded contract 75N93018C00018?
75N93018C00018 was awarded to Melax Technologies Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 18, 2018.
How much is contract 75N93018C00018 worth?
The government has obligated $599,998 on 75N93018C00018.
Was contract 75N93018C00018 competed?
The extent of competition for 75N93018C00018 was full and open competition. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award